Heparin-coated Wiktor stents in human coronary arteries (MENTOR Trial)
- 15 August 2000
- journal article
- clinical trial
- Published by Elsevier in The American Journal of Cardiology
- Vol. 86 (4), 385-389
- https://doi.org/10.1016/s0002-9149(00)00951-6
Abstract
No abstract availableKeywords
Funding Information
- Medtronic
This publication has 18 references indexed in Scilit:
- Preventive effects of the heparin-coated stent on restenosis in the porcine modelCatheterization and Cardiovascular Interventions, 1999
- Short- and long-term outcomes of Wiktor stent implantation at low versus high pressuresThe American Journal of Cardiology, 1999
- Randomized Multicenter Comparison of Conventional Anticoagulation Versus Antiplatelet Therapy in Unplanned and Elective Coronary StentingCirculation, 1998
- Randomised comparison of implantation of heparin-coated stents with balloon angioplasty in selected patients with coronary artery disease (Benestent II)The Lancet, 1998
- Heparin coating of tantalum coronary stents reduces surface thrombin generation but not factor IXa generationBlood Coagulation & Fibrinolysis, 1998
- Experimental Study of Thrombogenicity and Foreign Body Reaction Induced by Heparin-Coated Coronary StentsCirculation, 1997
- Reduction in Thrombotic Events With Heparin-Coated Palmaz-Schatz Stents in Normal Porcine Coronary ArteriesCirculation, 1996
- Heparin-Coated Palmaz-Schatz Stents in Human Coronary ArteriesCirculation, 1996
- Usefulness of the Wiktor Stent for treatment of threatened or acute closure complicating coronary angioplastyThe American Journal of Cardiology, 1994
- TiclopidineDrugs, 1990